MultiCell Technologies Inc (MCET)

[simon wagstaff]

The number of shares traded in a single day has nothing to do with the number of outstanding shares and the number of shares available for dilution. About 700 million shares remain to be diluted.

Sorry, your post was so nonsensical and irrelevant it took me a moment.

I can ask this question once again and get the usual answer. What is there at MCET of value?

Stent basically gone, seeking a 4th extension having done nothing and not responding to the non-performance clause.

Mct-125 patent expires 2019. Trial run by Amarin many years ago. Mcet "contracted" with a cro to run the trial but never announced it was out of business.

Mct 465 and Mct-485 just "started animal testing". Surely some data by now? Data on website is from 2006. 10-20 years from the clinic, if ever.

And it's just one guy, with a BA in accounting.

And a horde of lying pumpers.